Improve Medical USA, Inc.

Improve Medical USA, Inc. is a wholly-owned subsidiary of Improve Medical Instruments Co., Ltd. (ChiNext:300030), a publicly traded Chinese medical device manufacturer. The company operates as an authorized importer and full-service distributor of blood collection tubes, needle sets, and in vitro diagnostics (IVD) test products for the US clinical laboratory and nursing markets. Core product portfolio includes the IMPROVACUTER® line of blood collection tubes (EDTA and lithium heparin in standard and mini formats) and IMPROSAFE® multi-sample phlebotomy needles with integrated safety holders and blood collection sets. All products are FDA-registered and designed for preanalytical specimen collection and processing optimization. Beyond distribution, the company operates an OEM business providing custom manufacturing solutions for branded medical devices, maintains a BSL-2 laboratory in Carlsbad, California for research and development, and markets the Automatic Homogenization Processor for fecal specimen preparation. The company supports multiple business channels including direct distribution partnerships and a global distributor network. Target markets include clinical laboratories, hospitals, nursing facilities, and diagnostic service providers requiring high-quality preanalytical solutions. The company participates in industry conferences including Viticus Group WVC Annual Conference and PITTCON.